[{"arm_notes": "", "treatment_id": null, "treatment_name": "Control group (n= 80): each patient will receive one non-transparent bottle; containing 28 non-transparent capsules. The capsules will contain standard placebo formulation; consisting of 0.5% magnesium stearate; 1.0% aerosil; 30% pharmaceutical talc + starch q.s.p. The prescription will obey the following dosage: 1 capsule; 1 x daily; for 28 days.Intervention group (n= 80): each patient will receive one non-transparent bottle; containing 28 tablets of edoxaban 60 mg. The prescription will obey the following dosage: 1 tablet; 1 x daily; for 28 days.;D27.505.519.389.745.800.449.500", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1636, "treatment_name": "Edoxaban+moxifloxacine", "treatment_type": "Coagulation modifiers+antibiotics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Control group (n= 80): each patient will receive two non-transparent bottles; one containing 28 non-transparent capsules (bottle 1) and one containing 10 non-transparent capsules (bottle 2). The capsules will contain standard placebo formulation; consisting of 0.5% magnesium stearate; 1.0% aerosil; 30% pharmaceutical talc + starch q.s.p. The prescription will obey the following dosage: bottle 1: 1 capsule; 1 x daily; for 28 days; bottle 2: 1 capsule; 1 x daily; for 10 days.Intervention group (n= 80): each patient will receive two non-transparent bottles; one containing 28 tablets of edoxaban 60 mg (bottle 1) and one containing 10 tablets of moxofloxacin 400 mg (bottle 2). The prescription will obey the following dosage: bottle 1: 1 tablet; 1 x daily; for 28 days; bottle 2: 1 tablet; 1 x daily; for 10 days.;anticoagulante oral;antibioticoterapia", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]